It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients

Breast Cancer Research and Treatment

Volumn 50, Issue 1, 1998, Pages 37-46

  Gruenberger, Th ^a   Gorlitzer, M ^a   Soliman, Th ^a   Rudas, M ^a   Mittlboeck, M ^a   Gnant, M ^a   Reiner, A ^a   Teleky, B ^a   Seitz, W ^a   Jakesz, R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Breast conserving surgery; Elderly breast cancer; Local recurrence; Treatment without adjuvant radiotherapy

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL PSYCHOLOGY; MORBIDITY; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY;

AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MULTIVARIATE ANALYSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 7344262316     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006064608360     Document Type: Article

References (35)

1. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher ER, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham L, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russell I: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312: 665-673, 1985
2. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher ER, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L: Eight-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320: 822-828, 1989
3. Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, Marubini E, Del Vecchio M, Boracchi P, Marchini S, Merson M, Sacchini V, Riboldi G, Santoro G: Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 26: 668-670, 1990
4. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimberti V, Rasponi A, Di Re E, Squicciarini P, Salvadori B: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671-673, 1990
5. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338: 327-331, 1991
6. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, Zucali R, Zurrida S, Salvadori B: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328: 1587-1591, 1993
7. Hermann RE, Esselstyn CB, Grundfest-Broniatowski S, Steiger E, Vogt DP, Broughan TA, Dowden RV, Hardesty I, Medendrop SV, Boyett JM: Partial mastectomy without radiation is adequate treatment for patients with Stage 0 and 1 carcinoma of the breast. Surg Gyn Obst 177: 247-253, 1993
8. Liljegren G, Homberg L, Adami HO, Westerman G, Graffman S, Bergh J: Sector resection with or without postoperative radiotherapy for Stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 86: 717-722, 1994
9. Locker AP, Ellis IO, Morgan DAL, Elston CW, Mitchell A, Blarney RW: Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76: 890-894, 1989
10. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989
11. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, Corbett PJ: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683-689, 1992
12. Greening WP, Montgomery ACV, Gordon AB, Growing NFC: Quadrantic excision and axillary node dissection without radiation therapy: the long-term results of a selective policy in the treatment of Stage I breast cancer. Eur J Surg Onc 14: 221-225, 1988
13. Fisher ER, Anderson S, Redmond C, Fisher B: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP Protocol B-06. Sem Surg Onc 8: 161-166, 1992
14. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Roth J, Spitalier JM: Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65: 1867-1878, 1990
15. Fourquet A, Campana F, Zafrani B: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radial Oncol Biol Phys 17: 719-725, 1989
16. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H: Risk factors in breast-conservation therapy. J Clin Oncol 12: 653-660, 1994
17. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB: Pathological predictors of early recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer 53: 1049-1057, 1984
18. Fisher ER, Redmond C, Fisher B, Bass G: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Cancer 65: 2121-2128, 1990
19. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketner M: A randomized clinical trial evaluating Tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479-484, 1989
20. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks J, Verbeek A, Schnitt SJ, Silver B, Boyages J, Harris JR: The presence of an intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8: 113-118, 1990
21. Clemente CG, Boracchi P, Andreola S, Del Vecchio M, Veronesi P, Rilke FO: Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 69: 1396-1403, 1992
22. Gruenberger Th, Gorlitzer M, Soliman Th, Rudas M, Mittlboeck M, Goetzinger P, Gnant M, Reiner A, Teleky B, Seitz W, Jakesz R: Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammakarzinoms die postoperative Nachbestrahlung ersparen? Acta Chirurgica Austriaca 27: 269-273, 1995
23. Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67:2079-2082, 1991
24. Recht A, Houlihan MJ: Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. Ann Surg 222: 9-18, 1995
25. Reiner A, Spona J, Reiner G: Estrogen receptor analysis on biopses and tine-needle aspirates from human breast carcinoma. Am J Pathol 125: 443-449, 1986
26. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456-1461, 1995
27. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 88: 1659-1664, 1996
28. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348: 708-713, 1996
29. Liljegren G, Lindgren A, Bergh J, Nordgren H, Tahar L, Holmberg L: Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncology 8: 235-241, 1997
30. Moffat FL, Ketcham AS, Robinson DS, Legaspi A, Ghandur-Mnaymneh L, Hilsenbeck S: Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas. Arch Surg 125: 364-369, 1990
31. Cady B, Stone MD, Wayne J: New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218: 338-349, 1993
32. Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K: Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43: 73-86, 1997
33. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Tong D, Winter J, van Zijl K: Factors influencing local relapse and survival and results olsalvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A (4/5): 801-805, 1992
34. Stewart HJ, Prescott RJ, Forrest PA: Conservation therapy of breast cancer. Lancet ii: 168-169, 1989
35. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71-85, 1992